Current Perspectives on Ophthalmic Mycoses
نویسندگان
چکیده
منابع مشابه
Current perspectives on ophthalmic mycoses.
Fungi may infect the cornea, orbit and other ocular structures. Species of Fusarium, Aspergillus, Candida, dematiaceous fungi, and Scedosporium predominate. Diagnosis is aided by recognition of typical clinical features and by direct microscopic detection of fungi in scrapes, biopsy specimens, and other samples. Culture confirms the diagnosis. Histopathological, immunohistochemical, or DNA-base...
متن کاملMycoses in Thailand: current concerns.
Scytalidium dimidiatum is the leading cause of fungal foot diseases in Thailand, in contrast to similar studies in which dermatophytes have been identified as the predominant pathogens. By contrast, the prevalence of Candida albicans in our study was only 2.6 approximately 3.0%. Scytalidium fungal foot infection is clinically indistinguishable from that caused by dermatophytes and should be inc...
متن کاملCurrent perspectives on synovitis
Received: 6 October 1999 Accepted: 14 October 1999 Published: 26 October 1999 © Current Science Ltd Important note about how to cite this article This article is also available online in the Arthritis Research website. To avoid confusion, please ensure that only the online version of the article is cited in any reference, as follows: Tak PP, Breedveld FC: Current perspectives on synovitis [comm...
متن کاملCurrent perspectives on ranibizumab
BACKGROUND This review summarizes the Phase III studies addressing intravitreal ranibizumab treatment in patients with neovascular age-related macular degeneration (AMD), macular edema (ME) from retinal vein occlusion (RVO), and diabetic ME (DME). RESULTS The data from 12 major Phase III studies: six studies in patients with neovascular AMD, two studies in patients with ME from RVO, and four ...
متن کاملCurrent perspectives on statins.
Statins (HMG-CoA reductase inhibitors) are used widely for the treatment of hypercholesterolemia. They inhibit HMG-CoA reductase competitively, reduce LDL levels more than other cholesterol-lowering drugs, and lower triglyceride levels in hypertriglyceridemic patients. Statins are well tolerated and have an excellent safety record. Clinical trials in patients with and without coronary heart dis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Microbiology Reviews
سال: 2003
ISSN: 0893-8512,1098-6618
DOI: 10.1128/cmr.16.4.730-797.2003